期刊文献+

慢性肾脏病患者心血管事件相关预测因子 被引量:8

Predictors of Cardiovascular Event in Patients with Chronic Kidney Disease
下载PDF
导出
摘要 慢性肾脏病(CKD)患者逐年增加,心血管疾病作为其最主要的并发症,决定着CKD患者的预后。尽管目前临床医师已经对CKD患者进行了相对全面的检查,并已经使用药物对心脏功能进行早期的干预性治疗,但CKD患者心血管疾病并发症仍有很高的发生率及病死率。CK不仅仅是一个临床问题,肾脏替代治疗消耗大量的医疗资源,患者生活质量大大下降。近年来,心血管学科和肾脏学科医师强烈推荐,评估肾脏功能应该是心血管疾病患者诊断的一部分,同时肾脏病患者也应早期完善心血管疾病的相关检查。传统的心血管事件的危险因素对于预测CKD患者早期心血管事件风险似乎并不十分准确及全面,一些非传统性的因素,例如炎性介质及电解质近年来备受关注。 The number of patients with chronic kidney disease is increasing with years,and cardiovascular disease, as the main complication, determines the prognosis in patients with chronic kidney disease (CKD). Ahhoughrelatively comprehensive checkups of the CKD patients have been performed in clinical, and drugs have been used as early intervention treatment on cardiac function, the cardiovascular complications in CKD patients still have a high incidence and a high mortality. CKD is not just a clinical problem, and renal replacement therapy consumes a lot of medical resources, and the quality of life of CKD patients is greatly reduced. In recent years, cardiovascular and kidney discipline physicians strongly recommended that assessing renal function should be a part of the diagnosis of cardiovascular disease in patients, and in patients with kidney diseases early examination of cardiovascular disease should be improved. The traditional risk fac- tom to predict the risk of cardiovascular events seem to be inaccurate and incomprehensive in patients with chronic kidney disease. Some non-traditional factors, such as inflammatory mediators and electrolyte, have attracted much attention in recent years.
出处 《医学综述》 2016年第2期248-251,共4页 Medical Recapitulate
基金 黑龙江省卫生厅科研课题(2009-065) 黑龙江省青年科学基金(QC2010030)
关键词 慢性肾脏病 心血管 甲状旁腺激素 镁离子 维生素D 成纤维细胞生长因子23 Chronic kidney disease Cardiovascular Parathyroid hormone Magnesian ion Vitamin D Fibroblast growth factor 23
  • 相关文献

参考文献3

二级参考文献42

  • 1马莲环,刘建.ERK1/2的研究进展[J].国外医学(生理病理科学与临床分册),2005,25(3):279-282. 被引量:21
  • 2朱肖星,梅其炳,刘莉,吕顺艳,胡玉珍,张峰,陈定章,裴兆辉,袁文俊.内皮素-1对新生大鼠心肌细胞的影响及机制[J].心脏杂志,2005,17(5):441-444. 被引量:9
  • 3杨丽霞,王先梅,石燕昆,郭传明,齐峰,任丽.细胞外信号调节激酶的变化在心力衰竭患者心肌重构中的意义[J].心脏杂志,2006,18(1):62-64. 被引量:1
  • 4Joy MS, Karagiannis PC, Peyerl FW. Outcomes of secondary hyperparathyroidism in chronic kidney disease and the direct costs of treatment. J Manag Care Pharm,2007 ,13 :397-411.
  • 5Weiner DE, Tighiouart H, Vlagopoulos PT, et al. Effects of anemia and left ventricular hypertrophy on cardiovascular disease in patients with chronic kidney disease. J Am Soc Nephrol, 2005, 16:1803-1810.
  • 6Meijs MF, Bots ML, Vonken EJ, et al. Rationale and design of the SMART Heart study : A prediction model for left ventricular hypertrophy in hypertension. Neth Heart J, 2007, 15: 295-298.
  • 7Krauser DG, Devereux RB. Ventricular hypertrophy and hypertension : prognostic elements and implications for management. Herz, 2006, 31:305-316.
  • 8Shin SJ, Kim HW, Chung S, et al. Late referral to a nephrologist increases the risk of uremia-related cardiac hypertrophy in patients on hemodialysis. Nephron Clin Pract, 2007, 107 :c139-c146.
  • 9Mitsnefes MM, Kimball TR, Kartal J,et al. Progression of left ventricular hypertrophy in children with early chronic kidney disease : 2-year follow-up study. J Pediatr, 2006, 149:671-675.
  • 10Randon RB, Rohde LE, Comerlato L, et al. The role of secondary hyperparathyroidism in left ventricular hypertrophy of patients under chronic hemodialysis. Braz J Med Biol Res, 2005, 38: 1409-1416.

共引文献3

同被引文献77

引证文献8

二级引证文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部